PF-AtlasКлинические испытания › NCT02055456

Nandrolone Decanoate in the Treatment of Telomeropathies

Nandrolone Decanoate · Фаза 1

ID реестра
NCT02055456
Фаза
Фаза 1
Статус
Завершено
Препарат / вмешательство
Nandrolone Decanoate
Спонсор
University of Sao Paulo
Начало
2014-02-01
Набор участников
20
Центры
1

Об исследовании

Decrease in blood cell counts due to deficient bone marrow function, called bone marrow failure, as well as some lung diseases, called idiopathic pulmonary fibrosis, can be caused by genetic defects in telomere biology genes, eventually causing telomere erosion. These disorders are collectively termed "telomeropathies". There is evidence that male hormones may improve blood cell counts in marrow failure, and these hormones are able to stimulate telomerase function in hematopoietic cells in vitro. We propose this study to the use of male hormone in patients with aplastic anemia and pulmonary fibrosis associated with defects in telomeres.

Открыть NCT02055456 на ClinicalTrials.gov →

Связанные материалы

Медицинская оговорка. Эта страница обобщает публичные данные исследования NCT02055456 только для информации. Это не медицинская рекомендация, не одобрение и не предложение участия. Проверяйте детали на ClinicalTrials.gov и у квалифицированного врача.